Semnur Pharmaceuticals
Semnurpharma – Getting back to normal
United States · $6.0M raised
- Business Model
- B2B
- Website
- semnurpharma.com
- Total Funding
- $6.0M
- Last Round
- $6.0M SeedAug 2013
- Rounds
- 1
About
Biopharmaceutical company focused on pain management therapies; wholly owned subsidiary of Scilex Holding Company.
Summary
Semnur Pharmaceuticals is a Biotech company based in United States. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Aug 2013.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2013
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...